HHS medical innovation task force
HHS task force on medical innovation is seeking comments on how the department can speed access of medical products to consumers, a notice published in the Federal Register May 24 states. Submissions will be accepted until Aug. 23, and a report is expected by year end. HHS Secretary Thompson announced the formation of the task force, which will be chaired by Acting Commissioner Lester Crawford, in April (1"The Pink Sheet" May 3, 2004, p. 19)...
You may also be interested in...
An HHS task force will examine ways the government can help accelerate the process of medical innovation, Secretary Thompson said April 26
The independent, family-controlled German group has signed a third R&D pact with Danish biotech Gubra to develop poly-agonist peptides for obesity.
Inovio Pharmaceuticals has reported promising initial data from its first Phase III study of its electrical current-driven DNA plasmid-based immunotherapy, VGX-3100, in virus-associated cervical dysplasia; it is heading a small group of companies evaluating novel therapies in the condition, which often advances to cancer.